[Current state and prospects of the use of cygnoline in the treatment of psoriasis].
D000873:Anthracenes / Q000627:therapeutic use*; D000875:Anthralin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy*; D012869:Skin Absorption
D000873:Anthracenes; D004247:DNA; D000875:Anthralin
Aktualny stan i perspektywy stosowania cygnoliny w leczeniu łuszczycy.